Skip to search formSkip to main contentSkip to account menu

Arbitrary Fluorescence Units

Known as: AFU, Arbitrary Fluorescence Unit, {AFU} 
Arbitrary unit(s) of fluorescent luminescence.
National Institutes of Health

Related topics

Related topics

1 relation
Clinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Interest of short hormonotherapy (HT) associated with radiotherapy (RT) as salvage treatment for biological relapse (BR) after radical prostatectomy (RP): Results of the GETUG-AFU 16 phase III…
5006 Background: RT is the standard as salvage treatment after RP. The role of HT is not demonstrated to date. This trial… 
2012
2012
Synthesis of fluorescent Ag nanoclusters and their application in α-L-fucosidase detection.
Highly fluorescent Ag nanoclusters (NCs) were successfully prepared by a simple and nontoxic approach, and the as-prepared Ag NCs… 
2012
2012
Combined analysis of serum γ-glutamyl transferase isoenzyme II, α-L-fucosidase and α-fetoprotein detected using a commercial kit in the diagnosis of hepatocellular carcinoma
γ-glutamyl transferase isoenzyme II (GGT-II) is a sensitive biomarker of hepatocellular carcinoma (HCC). However, numerous… 
2009
2009
Crystal structure and assembly of the functional Nanoarchaeum equitans tRNA splicing endonuclease
The RNA splicing and processing endonuclease from Nanoarchaeum equitans (NEQ) belongs to the recently identified (αβ)2 family of… 
2007
2007
Development of an on-chip injector for microchip-based flow analyses using laminar flow.
A new on-chip injector for microchip-based flow analyses has been designed and characterized. The microchip design utilizes… 
2006
2006
Simultaneous determination of membrane CD64 and HLA-DR expression by blood neutrophils and monocytes using the monoclonal antibody fluorescence capability of a routine haematology analyser.
2003
2003
Combined use of established and novel tumour markers in the diagnosis of head and neck squamous cell carcinoma.
Serum SCC, CYFRA 21-1, and CEA are the common tumour markers for head and neck squamous cell carcinoma (HNSCC), although… 
2002
2002
Preoperative Serum Alpha-L-Fucosidase Activity as a Prognostic Marker in Colorectal Cancer
Objectives: The aim of this study was to examine the prognostic value of the preoperative serum α-L-fucosidase (AFU) activity in… 
2002
2002
Catecholaminergic projections onto spinal neurons destined to the pelvis including the penis in rat
In rats, the spinal cord contains proerectile autonomic motoneurons destined to the penile tissue and its vasculature, and… 
1999
1999
Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in Thailand.
To evaluate the role of serum alpha-L-fucosidase (AFU) in the diagnosis of hepatocellular carcinoma (HCC), we simultaneously… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)